151 related articles for article (PubMed ID: 1137503)
21. Present status of vaccines for rubella.
Sever JL
Arch Otolaryngol; 1973 Oct; 98(4):265-8. PubMed ID: 4205025
[No Abstract] [Full Text] [Related]
22. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
Naficy K; Nategh R; Ahangary S; Mohsenin H
Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
[No Abstract] [Full Text] [Related]
23. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
Rossier E; Phipps PH; Polley JR; Webb T
Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
[TBL] [Abstract][Full Text] [Related]
24. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
[TBL] [Abstract][Full Text] [Related]
25. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection.
Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA
Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740
[TBL] [Abstract][Full Text] [Related]
26. In vitro lymphocyte reactivity to rubella antigen following vaccination.
Heigl Z; Wasserman J; Forsgren M
Scand J Infect Dis; 1980; 12(1):13-20. PubMed ID: 6988953
[TBL] [Abstract][Full Text] [Related]
27. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
[TBL] [Abstract][Full Text] [Related]
28. Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus.
Vesikari T; Vaheri A; Leinikki P
Arch Gesamte Virusforsch; 1971; 35(1):25-37. PubMed ID: 4943281
[No Abstract] [Full Text] [Related]
29. Evaluation of possible transplacental infection with rubella vaccination during pregnancy.
Bolognese RJ; Corson SL; Fuccillo DA; Sever JL; Traub R
Am J Obstet Gynecol; 1973 Dec; 117(7):939-41. PubMed ID: 4759831
[No Abstract] [Full Text] [Related]
30. Experimental active and passive immunization against rubella.
Budai J; Tóth M; Melis L
Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
[No Abstract] [Full Text] [Related]
31. Stability of the rabbit immunogenic marker of RA 27-3 rubella vaccine virus after human passage.
Linnemann CC; Hutchinson L; Rotte TC; Hegg ME; Schiff GM
Infect Immun; 1974 Mar; 9(3):547-9. PubMed ID: 4206028
[TBL] [Abstract][Full Text] [Related]
32. Persistence of Immunity Acquired after a Single Dose of Rubella Vaccine in Japan.
Okafuji T; Okafuji T; Nakayama T
Jpn J Infect Dis; 2016 May; 69(3):221-3. PubMed ID: 26255735
[TBL] [Abstract][Full Text] [Related]
33. Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers.
Kauffman CA; Phair JP; Linnemann CC; Schiff GM
Infect Immun; 1974 Jul; 10(1):212-5. PubMed ID: 4546284
[TBL] [Abstract][Full Text] [Related]
34. Live attenuated rubella virus vaccines in young adult women. Trials of Cendehill and HPV-77 DE-5.
Byrne EB; Ryan JM; Randolph MF; Horstmann DM
Am J Dis Child; 1969 Aug; 118(2):234-6. PubMed ID: 4183351
[No Abstract] [Full Text] [Related]
35. Challenge with rubella virus after loss of detectable vaccine-induced antibody.
Schiff GM; Young BC; Stefanovic' GM; Stamler EF; Knowlton DR; Grundy BJ; Dorsett PH
Rev Infect Dis; 1985; 7 Suppl 1():S157-63. PubMed ID: 4001723
[TBL] [Abstract][Full Text] [Related]
36. Abnormalities of in vitro lymphocyte responses during rubella virus infections.
Olson GB; Dent PB; Rawls WE; South MA; Montgomery JR; Melnick JL; Good RA
J Exp Med; 1968 Jul; 128(1):47-68. PubMed ID: 5662017
[TBL] [Abstract][Full Text] [Related]
37. Reinfection with rubella virus despite live vaccine induced immunity. Trials of HPV-77 and HPV-80 live rubella virus vaccines and subsequent artificial and natural challenge studies.
Wilkins J; Leedom JM; Portnoy B; Salvatore MA
Am J Dis Child; 1969 Aug; 118(2):275-94. PubMed ID: 5794818
[No Abstract] [Full Text] [Related]
38. In vivo properties of attenuated rubella virus, "Cendehill" strain.
Zygraich N; Peetermans J; Huygelen C
Arch Gesamte Virusforsch; 1971; 33(3):225-33. PubMed ID: 5000190
[No Abstract] [Full Text] [Related]
39. A study of rubella immunity and resistance to infection.
Davis WJ; Larson HE; Simsarian JP; Parkman PD; Meyer HM
JAMA; 1971 Jan; 215(4):600-8. PubMed ID: 5107436
[No Abstract] [Full Text] [Related]
40. Production of rubella virus vaccine. Live, attenuated in canine renal cell cultures.
Musser SJ; Hilsabeck LJ
Am J Dis Child; 1969 Aug; 118(2):355-61. PubMed ID: 4978513
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
